Published in J Nat Prod on November 08, 1991
Uncaria tomentosa exerts extensive anti-neoplastic effects against the Walker-256 tumour by modulating oxidative stress and not by alkaloid activity. PLoS One (2013) 0.78
The Quinovic Acid Glycosides Purified Fraction from Uncaria tomentosa Protects against Hemorrhagic Cystitis Induced by Cyclophosphamide in Mice. PLoS One (2015) 0.75
Root Canal Irrigation: Chemical Agents and Plant Extracts Against Enterococcus faecalis. Open Dent J (2016) 0.75
Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature (1998) 4.65
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med (2000) 3.37
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med (2001) 3.17
Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol (1999) 2.66
A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology (1995) 2.30
Antioxidant principles from Bauhinia tarapotensis. J Nat Prod (2001) 2.18
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Protective immune response against foot-and-mouth disease. J Virol (1992) 1.77
Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology (1994) 1.76
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature (1987) 1.63
Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest (1995) 1.55
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol (2007) 1.45
Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol (2008) 1.40
Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A (2001) 1.39
Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine (2006) 1.35
A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol (1994) 1.28
Molecular analysis of encephalomyocarditis viruses isolated from pigs and rodents in Italy. Virus Res (1998) 1.27
The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol (1997) 1.27
NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther (1997) 1.26
Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology (1986) 1.24
Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci (1989) 1.19
Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br J Pharmacol (2000) 1.18
Partial characterization of an 89-kDa highly immunoreactive protein from Chlamydia psittaci A/22 causing ovine abortion. FEMS Microbiol Lett (1991) 1.16
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol (2000) 1.14
Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol (2001) 1.14
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol (2000) 1.14
Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation (1999) 1.13
Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology (1987) 1.12
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci (1998) 1.11
Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci U S A (2000) 1.11
Screening of the topical anti-inflammatory activity of some Central American plants. J Ethnopharmacol (2002) 1.11
Volatile anesthetics for periprocedural cardiac protection. A review. Minerva Cardioangiol (2008) 1.10
Pharmacological characterization of polycation-induced rat hind-paw oedema. Br J Pharmacol (1990) 1.10
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2001) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Small-intestinal bleeding due to metastatic renal cell cancer. Endoscopy (2011) 1.07
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. Biochim Biophys Acta (1986) 1.06
Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol (1989) 1.06
Traditional phytotherapy in the Roccamonfina volcanic group, Campania, southern Italy. J Ethnopharmacol (1988) 1.06
Halipeptins A and B: two novel potent anti-inflammatory cyclic depsipeptides from the Vanuatu marine sponge Haliclona species. J Am Chem Soc (2001) 1.06
The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena. Biochem Biophys Res Commun (1996) 1.04
Isoquinoline alkaloids from Argemone mexicana reduce morphine withdrawal in guinea pig isolated ileum. Planta Med (1997) 1.03
Screening of anti-bacterial activity of medicinal plants from Belize (Central America). J Ethnopharmacol (2003) 1.03
Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am J Physiol (1989) 1.02
Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sci (1998) 1.00
Effects of endothelin-1 on the rat isolated heart. J Cardiovasc Pharmacol (1989) 1.00
Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells. Cell Death Differ (2004) 1.00
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
Immunological characterization of a low molecular mass polypeptidic antigen of Borrelia burgdorferi. FEMS Microbiol Immunol (1991) 0.99
Variable expression and geographic distribution of Mycoplasma agalactiae surface epitopes demonstrated with monoclonal antibodies. FEMS Microbiol Lett (1996) 0.98
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016. Thromb Res (1999) 0.97
Mast cell degranulation induced by two phospholipase A2 homologues: dissociation between enzymatic and biological activities. Eur J Pharmacol (1998) 0.96
Studies on the inhibitory effects of caffeoylquinic acids on monocyte migration and superoxide ion production. J Nat Prod (1995) 0.96
Observations on the inhibition of HIV-1 reverse transcriptase by catechins. Biochem J (1992) 0.95
Bronchodilator, vasodilator and spasmolytic activities of methanolic extract of Myrtus communis L. J Physiol Pharmacol (2013) 0.95
Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. J Pharmacol Methods (1988) 0.94
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha. Aliment Pharmacol Ther (1999) 0.94
Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma. Clin Exp Allergy (2007) 0.94
Enhanced in vitro phagocytic power of macrophages from PPD-stimulated skin sites in human subjects hypersensitive to PPD. Clin Exp Immunol (1973) 0.93
Traditional phytotherapy in the Agri Valley, Lucania, southern Italy. J Ethnopharmacol (1982) 0.93
Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils. Am J Physiol (1997) 0.93
Hypoglycemic effects of sesquiterpene glycosides and polyhydroxylated triterpenoids of Eriobotrya japonica. Planta Med (1991) 0.92
Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats. Am J Physiol Heart Circ Physiol (2000) 0.92
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91
The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci (1994) 0.90
Antimicrobial activity of Mitracarpus scaber extract and isolated constituents. Lett Appl Microbiol (2000) 0.90
Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90
Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea-pigs in vivo. Br J Pharmacol (1999) 0.89
Pharmacological dissection of vascular effects caused by activation of protease-activated receptors 1 and 2 in anesthetized rats. FASEB J (2001) 0.89
Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease. J Lipid Mediat (1992) 0.88
Screening of the topical anti-inflammatory activity of the bark of Acacia cornigera Willdenow, Byrsonima crassifolia Kunth, Sweetia panamensis Yakovlev and the leaves of Sphagneticola trilobata Hitchcock. J Ethnopharmacol (2009) 0.88
Development of two novel monoclonal antibody-based ELISAs for the detection of antibodies and the identification of swine isotypes against swine vesicular disease virus. J Virol Methods (1995) 0.88
Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci U S A (1998) 0.88
Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. Br J Pharmacol (1995) 0.87
Hexanic Maca extract improves rat sexual performance more effectively than methanolic and chloroformic Maca extracts. Andrologia (2002) 0.87
Flavonoids reduce morphine withdrawal in-vitro. J Pharm Pharmacol (1998) 0.87
Neutralization tests for foot-and-mouth disease, equine rhino-, porcine entero-, Aujeszky- and rhinopneumonitis viruses. Comparison of results obtained by a simple microculture plaque reduction test and various traditional tests. Zentralbl Veterinarmed B (1972) 0.87
Simultaneous occurrence of spongiform encephalopathy in a man and his cat in Italy. Lancet (1998) 0.87
Conformational alteration in foot-and-mouth disease virus virion capsid structure after complexing with monospecific antibody. Immunology (1987) 0.87
Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity. J Gastroenterol Hepatol (1994) 0.87
Antiproliferative and pro-apoptotic activity of novel phenolic derivatives of resveratrol. Life Sci (2007) 0.86
Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site. J Gen Virol (1992) 0.86
Analysis of protease-activated receptor-1 and -2 in human scar formation. J Pathol (2007) 0.86
Outstanding effects on antithrombin activity of modified TBA diastereomers containing an optically pure acyclic nucleotide analogue. Org Biomol Chem (2014) 0.86
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2011) 0.86
Mechanisms of prostaglandin E2 release by intact cells expressing cyclooxygenase-2: evidence for a 'two-component' model. J Pharmacol Exp Ther (1999) 0.86
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.86
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer. Br J Cancer (2005) 0.86
The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line. Anticancer Res (2001) 0.85
Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. J Clin Pathol (2004) 0.85
Alfalfa (Medicago sativa L.) flavonoids. 1. Apigenin and luteolin glycosides from aerial parts. J Agric Food Chem (2001) 0.85
Constituents of Eriobotrya japonica. A study of their antiviral properties. J Nat Prod (1992) 0.85
Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. Int J Immunopathol Pharmacol (2012) 0.85